| Literature DB >> 27155015 |
Yi Huang1, Yu Huang2, Aoshuang Chang3, Jishi Wang1, Xiaoqing Zeng1, Jiahong Wu3.
Abstract
BACKGROUND Possible associations of parasite infection with cancer risk have recently attracted much attention. Published studies concerning the association between Toxoplasma gondii (T. gondii) infection and leukemia risk have generated inconsistent results. In the present study, we aimed to address this topic by conducting a quantitative meta-analysis. MATERIAL AND METHODS Relevant publications were searched in electronic databases and eligible studies were rigorously screened and selected. Essential information was extracted and the data were pooled. Subgroup analysis on source of controls and detection target was also performed. RESULTS A total of 6 studies that met the inclusion criteria were selected. The overall data show that T. gondii infection might have an association with increased leukemia risk (OR=3.05; 95%CI=1.83-5.08). Similar results were shown in the subgroups regarding source of controls and detection target. CONCLUSIONS Our results suggest that T. gondii infection might be a risk factor for leukemia, providing new insight into the etiology of leukemia. Future studies with large sample sizes in different geographic areas are needed to confirm this conclusion.Entities:
Mesh:
Year: 2016 PMID: 27155015 PMCID: PMC4917333 DOI: 10.12659/msm.897155
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Flow diagram of included/excluded studies.
Characteristics of studies included in the meta-analysis.
| First author | Year | No. and type of cases | Cases | No. and type of controls | Controls | Method for diagnosis of | Target of detection | Area | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | |||||||
| Peng | 2004 | 10 leukemia | 4 | 6 | 75 healthy controls (PB) | 4 | 71 | IHT | Toxoplasma IgG | China |
| Cheng | 2001 | 93 leukemia (47 acute; 26 chronic; 20 recurrent) | 14 | 79 | 151 Non-cancerous controls (HB) | 5 | 146 | PCR probe | Toxoplasma DNA | China |
| Gulesci | 2005 | 25 leukemia | 16 | 9 | 40 Non-cancerous controls (HB, age-, sex-matched) | 25 | 15 | IFA | Toxoplasma IgG | Turkey |
| Yang | 2005 | 46 leukemia | 8 | 38 | 20 healthy controls (PB) | 0 | 20 | PCR | Toxoplasma DNA | China |
| Chang | 2007 | 58 leukemia | 4 | 54 | 20 healthy controls (PB) | 0 | 20 | PCR | Toxoplasma DNA | China |
| Tian | 2015 | 150 leukemia | 24 | 126 | 110 healthy controls (PB) | 7 | 103 | ELISA | Toxoplasma IgG | China |
IHT – indirect hemagglutination test;
IFA – indirect immunofluorescence assa;
PCR – polymerase chain reaction;
ELISA – enzyme-linked immunosorbent assay.
Main results of the meta-analysis.
| Factors | Overall OR (95%CI) | z | P | Heterogeneity test | Number of studies | Model | |
|---|---|---|---|---|---|---|---|
| Q | P | ||||||
| Total (case | 3.05 (1.83, 5.08) | 4.29 | 0.000 | 8.18 | 0.147 | 6 | Fixed-effect |
| Stratification by source of controls | |||||||
| PB | 3.85 (1.84, 8.08) | 3.57 | 0.000 | 2.69 | 0.442 | 4 | Fixed-effect |
| HB | 2.38 (1.17, 4.84) | 2.38 | 0.017 | 4.37 | 0.037 | 2 | Fixed-effect |
| Stratification by target of detection | |||||||
| Toxoplasma IgG | 2.32 (1.26, 4.28) | 2.69 | 0.007 | 6.23 | 0.044 | 3 | Fixed-effect |
| Toxoplasma DNA | 5.39 (2.08, 14.01) | 3.46 | 0.001 | 0.22 | 0.895 | 3 | Fixed-effect |
PB – population-based;
HB – hospital-based.
Figure 2Meta-analysis of the association of leukemia risk with T. gondii infection (case vs. control).
Figure 3Publication bias test for the overall data (case vs. control) (A) Funnel plot; (B) Egger’s linear regression test.